Pharmafile Logo

Top-10 ways that Pharma teams can fight the climate crisis

Ten easy steps that individual medical, marketing, clinical, regulatory, and market access teams can take to reduce their own footprints.

I recently attended a webinar called “Pharma’s climate goals: The roadmap to delivery.” It was an eye-opening discussion focused on the big changes that pharmaceutical organizations need to implement to reduce their carbon footprint. In this top-10 article, I wanted to build on the insights shared during that webinar, with a focus on the smaller–but just as important–steps that individual medical, marketing, clinical, regulatory, and market access teams can take to reduce their own footprints, contributing to their organizations’ bottom lines. These include:

1. Set clear short-, mid-, and long-term goals
2. Reduce your energy use or switch to sustainable sources of energy
3. Continue to let your team work remotely or flexibly
4. Consider decentralized trials
5. Take a critical look at your supply chain

Read the full top-10 list of ways that Pharma teams can reduce their environmental footprint and fight the climate crisis here.

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Top 10 Tips for Creating Company Culture in a Virtual World

Remote work is here to stay. Learn how companies and employees can thrive in this new environment

Strategies to Launch and Commercialize Healthcare Innovations

Dr. Roxie Mooney, Healthcare Commercialization Strategist at Legacy DNA and best-selling author, joins Natalie Yeadon, Co-owner & Managing Director at Impetus Digital. We are discussing all things healthcare innovation and commercialization,...

Patient-Centered Digital Transformation

Lygeia Ricciardi, Advisor at Carium, joins Natalie Yeadon, Co-Founder & CEO at Impetus Digital in this Fireside Chat. They explore a variety of topics related to patient-centric care, digital health transformation,...

Effects of the Pandemic on Evidence Generation & Scientific Exchange

Farah Husein, Director, Evidence Generation, Canadian Centre of Excellence, at Takeda, discusses all things evidence generation, including the impact of the COVID-19 pandemic on HEOR, RWE, epidemiology, and PRO studies and...

Press release: InSite Event™ named one of the most innovative services of 2020

Press ReleaseContact: Jess Masciangelo, Business Development Directorjmasciangelo@impetusdigital.commeetwithimpetus.comINSITE EVENT™ NAMED ONE OF THE MOST INNOVATIVE SERVICES OF 2020Toronto, ON, December 10, 2020 — Impetus Digital’s new virtual event platform InSite Event™...

The Future of Wearable and Implantable Devices

Nance Dicciani & Denise Devine, Co-founders of RTM Vital Signs, join Natalie Yeadon, Co-Founder & CEO at Impetus Digital. We explore continuous ambulatory vital sign monitoring using wearable and implantable devices....

Designing Ethical AI and Healthcare Technologies

Bryn Williams-Jones, Professor & Director of the Bioethics Program at ESPUM and Editor-in-Chief of the Canadian Journal of Bioethics discusses the bioethical challenges of innovative healthcare technologies such as AI, digital therapeutics,...

Attacking COVID-19 from All Angles

Michael Taylor, CEO & Founder of Environmental Surface Solutions, explores alternative and supplementary approaches to fighting COVID-19 and other pathogens. In particular, we focus on environmental solutions for not only eradicating...

Importance of Patient Advocacy in Improving Healthcare

Eva Villalba, Executive Director of the Quebec Cancer Coalition, explores the importance of patient advocacy in improving healthcare. Among many other things, we dive into how the industry can help support...

Improving Patient Care by Removing Barriers to Drug Accessibility

Alan Birch, Founder & President of Drug Access Canada, discusses all things drug access and reimbursement. Among many other things, we explore the hurdles faced by patients and drug access navigators and...